Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-4367 in Patients With Prostate Cancer and Healthy Volunteers
Visual assessment of diagnostic PET/CT (positron emission tomography/computed tomography) images obtained after a single intravenous injection of BAY86-4367 in patients with cancer
Diagnostic Imaging
DRUG: BAY86-4367|DRUG: BAY86-4367
Visual assessment of lesions, Day of study drug administration
Quantitative analysis of BAY86-4367 uptake into lesions (Standardized Uptake Values = SUVs), Day of study drug administration|Electrocardiogram (ECG), At least 3 times within 8 days after treatment|Blood pressure, At least 3 times within 8 days after treatment|Serum protein, At least 3 times within 8 days after treatment|Serum creatinine, At least 3 times within 8 days after treatment|Serum GOT (Glutamat-Oxalacetat-Transaminase), At least 3 times within 8 days after treatment|Adverse events collection, At least 3 times within 8 days after treatment
Visual assessment of diagnostic PET/CT (positron emission tomography/computed tomography) images obtained after a single intravenous injection of BAY86-4367 in patients with cancer